OSE Immunotherapeutics Presents its Novel Bispecific Checkpoint Inhibitor Platform, Targeting PD-1 and Innovative Targets at the 2019 World Immunotherapy Congress

NEXT STORY
Union leaders representing more than 200,000 nurses, health professionals and care workers demand public consultation on Ford government’s omnibus health care bill
PREV STORY
Oxurion NV Business Update – FY 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science annonce que les résultats de l’étude AB07015 du masitinib dans l’asthme sévère ont été sélectionnés pour être présentés au colloque de l’ATS qui se tiendra le 16 octobre 2020

author_avatar
NASDAQ Market News

Global Next Generation Sequencing Market Will Reach USD 9,891 Million By 2026: Zion Market Research

author_avatar
NASDAQ Market News

Home Healthcare Market 2020 Surprising Growth due to Covid 19 include Major Players Koninklijke Philips N.V., Air Liquide, Amedisys, Apple Home Healthcare, Arcadia and others

author_avatar
NASDAQ Market News